RNS Number:1767L
Tepnel Life Sciences PLC
16 May 2003


FOR IMMEDIATE RELEASE



                                                                     16 May 2003


Tepnel Life Sciences PLC ('Tepnel' or 'the Company') Announces

Resignation of Peter Raymond, Non-executive Chairman



Manchester, UK. 16 May 2003...Tepnel Life Sciences PLC (AIM: TED), the UK-based
international life sciences instrumentation and services company, announces
today that Peter Raymond, the Company's Non-executive Chairman has resigned from
the Board of Directors with immediate effect.



Ben Matzilevich, Tepnel's CEO, said "I would like to thank Peter for 11 years of
guidance and leadership, during which time Tepnel has matured from a university
spin-out through an IPO to its current position as a successful business selling
products and services to a wide range of pharmaceutical companies around the
world."



Alec Craig, a Non-executive Director of Tepnel and Senior Partner of London and
Manchester based law firm, Halliwell Landau, will be acting Chairman until a
replacement is appointed.



                                     -ends-



For Further Information:



Tepnel Life Sciences plc
Ben Matzilevich, CEO

Gron Ffoulkes-Davies, Finance Director

0161 946 2200



Halliwell Landau

Alec Craig

0161 831 2691



HCC De Facto Group

David Dible / Mark Swallow

020 7496 3300





Notes to Editors



Tepnel Life Sciences is a UK-based international life sciences instrumentation
and services company with a 'tri-polar' strategy focused on providing the
biomedical industry with high-throughput automated DNA purification systems,
manual DNA purification kits and reagents, as well as scientific services for
nucleic acid purification, drug analysis, genotyping and genetically modified
foods.



The Company was founded in 1992 to exploit DNA technology generated at UMIST
(University of Manchester Institute of Science and Technology) and is quoted on
the AIM segment of the London Stock Exchange (AIM: TED).



www.tepnel.com




                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

BOAGUUQAAUPWGMA